Growth Metrics

Orthopediatrics (KIDS) Shares Outstanding (Diluted Average) (2019 - 2025)

Orthopediatrics has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $23.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $23.5 million for Q4 2025, up 1.65% from a year ago — trailing twelve months through Dec 2025 was $23.5 million (up 1.65% YoY), and the annual figure for FY2025 was $23.5 million, up 1.65%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $23.5 million at Orthopediatrics, roughly flat from $23.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for KIDS hit a ceiling of $23.5 million in Q4 2025 and a floor of $19.2 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $22.7 million (2023), compared with a mean of $21.7 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 16.9% in 2021 and later rose 0.87% in 2022.
  • Orthopediatrics' Shares Outstanding (Diluted Average) stood at $19.3 million in 2021, then rose by 8.72% to $20.9 million in 2022, then grew by 8.25% to $22.7 million in 2023, then increased by 1.77% to $23.1 million in 2024, then rose by 1.65% to $23.5 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $23.5 million (Q4 2025), $23.4 million (Q3 2025), and $23.3 million (Q2 2025) per Business Quant data.